Seoane-Vazquez, Enrique
Rodriguez-Monguio, Rosa
Powers, John H. III
Funding for this research was provided by:
Laura and John Arnold Foundation (20-05204)
Article History
Received: 24 July 2023
Accepted: 1 February 2024
First Online: 9 February 2024
Competing interests
: John H. Powers reported consulting for Arrevus, Eicos, Eli Lilly, Evofem, Eyecheck, Fuji, Gilead, GlaxoSmithKline, Johnson & Johnson, Microbion, OPKO, Otsuka, Resolve, Romark, Shinogi, SpineBioPharma, UTIlity, Vir outside the submitted work. No other disclosures are reported.